Enlivex Therapeutics Ltd. (ENLV)
ENLV Stock Price Chart
Explore Enlivex Therapeutics Ltd. interactive price chart. Choose custom timeframes to analyze ENLV price movements and trends.
ENLV Company Profile
Discover essential business fundamentals and corporate details for Enlivex Therapeutics Ltd. (ENLV) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
31 Jul 2014
Employees
71.00
Website
https://www.enlivex.comCEO
Oren Hershkovitz
Description
Enlivex Therapeutics Ltd. operates as a clinical-stage macrophage reprogramming immunotherapy company. It is developing Allocetra, a cell-based therapy to treat organ dysfunction and failure associated with sepsis that is in phase II clinical trial, as well as in preclinical trial to treat solid tumors. Enlivex Therapeutics Ltd. was founded in 2005 and is headquartered in Nes Ziona, Israel.
ENLV Financial Timeline
Browse a chronological timeline of Enlivex Therapeutics Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 5 Dec 2025
EPS estimate is -$0.12.
Earnings released on 29 Aug 2025
EPS came in at -$0.08 surpassing the estimated -$0.16 by +50.00%.
Earnings released on 30 May 2025
EPS came in at -$0.15 surpassing the estimated -$0.16 by +6.25%.
Earnings released on 26 Feb 2025
EPS came in at -$0.24 falling short of the estimated -$0.16 by -47.75%.
Earnings released on 29 Nov 2024
EPS came in at -$0.12 surpassing the estimated -$0.16 by +25.00%.
Earnings released on 30 Aug 2024
EPS came in at -$0.16 surpassing the estimated -$0.22 by +27.27%.
Earnings released on 14 Jun 2024
EPS came in at -$0.22 surpassing the estimated -$0.25 by +12.00%.
Earnings released on 29 Mar 2024
EPS came in at -$0.48 falling short of the estimated -$0.28 by -71.43%.
Earnings released on 9 Nov 2023
EPS came in at -$0.32 matching the estimated -$0.32.
Earnings released on 1 Sept 2023
EPS came in at -$0.37 surpassing the estimated -$0.43 by +13.95%.
Earnings released on 4 Apr 2023
EPS came in at -$0.39 surpassing the estimated -$0.40 by +2.50%.
Earnings released on 31 Mar 2023
EPS came in at -$0.39 falling short of the estimated -$0.38 by -2.63%.
Earnings released on 5 Dec 2022
EPS came in at -$0.31 falling short of the estimated -$0.29 by -6.90%.
Earnings released on 22 Aug 2022
EPS came in at -$0.54 falling short of the estimated -$0.45 by -20.00%.
Earnings released on 27 May 2022
EPS came in at -$0.45 falling short of the estimated -$0.41 by -9.76%.
Earnings released on 29 Apr 2022
EPS came in at -$0.26 surpassing the estimated -$0.28 by +7.14%.
Earnings released on 22 Nov 2021
EPS came in at -$0.19 surpassing the estimated -$0.21 by +9.52%.
Earnings released on 9 Aug 2021
EPS came in at -$0.17 surpassing the estimated -$0.26 by +34.62%.
Earnings released on 1 Jun 2021
EPS came in at -$0.19 surpassing the estimated -$0.21 by +9.52%.
Earnings released on 30 Apr 2021
EPS came in at -$0.43 , while revenue for the quarter reached $2.28M .
Earnings released on 30 Oct 2020
EPS came in at -$0.16 surpassing the estimated -$0.18 by +11.11%.
ENLV Stock Performance
Access detailed ENLV performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.